Cargando…

Telehealth mitigates COPD disease progression compared to standard of care: a randomized controlled crossover trial

BACKGROUND: We showed excellent adherence and satisfaction with our telehealth care (TC) approach for COPD. Here, the results of a consecutive randomized controlled trial are presented. METHODS: Patients were randomly assigned to TC or standard care (SC). During TC, patients answered six daily quest...

Descripción completa

Detalles Bibliográficos
Autores principales: Rassouli, F., Germann, A., Baty, F., Kohler, M., Stolz, D., Thurnheer, R., Brack, T., Kähler, C., Widmer, S., Tschirren, U., Sievi, N. A., Tamm, M., Brutsche, M. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986739/
https://www.ncbi.nlm.nih.gov/pubmed/33428219
http://dx.doi.org/10.1111/joim.13230
_version_ 1783668502665625600
author Rassouli, F.
Germann, A.
Baty, F.
Kohler, M.
Stolz, D.
Thurnheer, R.
Brack, T.
Kähler, C.
Widmer, S.
Tschirren, U.
Sievi, N. A.
Tamm, M.
Brutsche, M. H.
author_facet Rassouli, F.
Germann, A.
Baty, F.
Kohler, M.
Stolz, D.
Thurnheer, R.
Brack, T.
Kähler, C.
Widmer, S.
Tschirren, U.
Sievi, N. A.
Tamm, M.
Brutsche, M. H.
author_sort Rassouli, F.
collection PubMed
description BACKGROUND: We showed excellent adherence and satisfaction with our telehealth care (TC) approach for COPD. Here, the results of a consecutive randomized controlled trial are presented. METHODS: Patients were randomly assigned to TC or standard care (SC). During TC, patients answered six daily questions online, and focused on the early recognition of exacerbations, in addition to SC. RESULTS: The mean increase in COPD assessment test (CAT) was 1.8 vs. 3.6 points/year in the TC and SC groups, respectively (P = 0.0015). Satisfaction with care (VAS) at baseline was 8.2; at the end of SC, 8.5 (P = 0.062); and after TC, 8.8 (P < 0.001). We detected significantly more moderate exacerbations during TC. CONCLUSION: Whilst receiving TC, the slope of the CAT increase – an indicator of the naturally progressive course of COPD – was reduced by 50%. Satisfaction with care increased with TC. The higher number of detected moderate exacerbations probably indicates a higher diagnostic sensitivity than without TC.
format Online
Article
Text
id pubmed-7986739
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-79867392021-03-25 Telehealth mitigates COPD disease progression compared to standard of care: a randomized controlled crossover trial Rassouli, F. Germann, A. Baty, F. Kohler, M. Stolz, D. Thurnheer, R. Brack, T. Kähler, C. Widmer, S. Tschirren, U. Sievi, N. A. Tamm, M. Brutsche, M. H. J Intern Med Brief Reports BACKGROUND: We showed excellent adherence and satisfaction with our telehealth care (TC) approach for COPD. Here, the results of a consecutive randomized controlled trial are presented. METHODS: Patients were randomly assigned to TC or standard care (SC). During TC, patients answered six daily questions online, and focused on the early recognition of exacerbations, in addition to SC. RESULTS: The mean increase in COPD assessment test (CAT) was 1.8 vs. 3.6 points/year in the TC and SC groups, respectively (P = 0.0015). Satisfaction with care (VAS) at baseline was 8.2; at the end of SC, 8.5 (P = 0.062); and after TC, 8.8 (P < 0.001). We detected significantly more moderate exacerbations during TC. CONCLUSION: Whilst receiving TC, the slope of the CAT increase – an indicator of the naturally progressive course of COPD – was reduced by 50%. Satisfaction with care increased with TC. The higher number of detected moderate exacerbations probably indicates a higher diagnostic sensitivity than without TC. John Wiley and Sons Inc. 2021-01-11 2021-03 /pmc/articles/PMC7986739/ /pubmed/33428219 http://dx.doi.org/10.1111/joim.13230 Text en © 2021 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Reports
Rassouli, F.
Germann, A.
Baty, F.
Kohler, M.
Stolz, D.
Thurnheer, R.
Brack, T.
Kähler, C.
Widmer, S.
Tschirren, U.
Sievi, N. A.
Tamm, M.
Brutsche, M. H.
Telehealth mitigates COPD disease progression compared to standard of care: a randomized controlled crossover trial
title Telehealth mitigates COPD disease progression compared to standard of care: a randomized controlled crossover trial
title_full Telehealth mitigates COPD disease progression compared to standard of care: a randomized controlled crossover trial
title_fullStr Telehealth mitigates COPD disease progression compared to standard of care: a randomized controlled crossover trial
title_full_unstemmed Telehealth mitigates COPD disease progression compared to standard of care: a randomized controlled crossover trial
title_short Telehealth mitigates COPD disease progression compared to standard of care: a randomized controlled crossover trial
title_sort telehealth mitigates copd disease progression compared to standard of care: a randomized controlled crossover trial
topic Brief Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986739/
https://www.ncbi.nlm.nih.gov/pubmed/33428219
http://dx.doi.org/10.1111/joim.13230
work_keys_str_mv AT rassoulif telehealthmitigatescopddiseaseprogressioncomparedtostandardofcarearandomizedcontrolledcrossovertrial
AT germanna telehealthmitigatescopddiseaseprogressioncomparedtostandardofcarearandomizedcontrolledcrossovertrial
AT batyf telehealthmitigatescopddiseaseprogressioncomparedtostandardofcarearandomizedcontrolledcrossovertrial
AT kohlerm telehealthmitigatescopddiseaseprogressioncomparedtostandardofcarearandomizedcontrolledcrossovertrial
AT stolzd telehealthmitigatescopddiseaseprogressioncomparedtostandardofcarearandomizedcontrolledcrossovertrial
AT thurnheerr telehealthmitigatescopddiseaseprogressioncomparedtostandardofcarearandomizedcontrolledcrossovertrial
AT brackt telehealthmitigatescopddiseaseprogressioncomparedtostandardofcarearandomizedcontrolledcrossovertrial
AT kahlerc telehealthmitigatescopddiseaseprogressioncomparedtostandardofcarearandomizedcontrolledcrossovertrial
AT widmers telehealthmitigatescopddiseaseprogressioncomparedtostandardofcarearandomizedcontrolledcrossovertrial
AT tschirrenu telehealthmitigatescopddiseaseprogressioncomparedtostandardofcarearandomizedcontrolledcrossovertrial
AT sievina telehealthmitigatescopddiseaseprogressioncomparedtostandardofcarearandomizedcontrolledcrossovertrial
AT tammm telehealthmitigatescopddiseaseprogressioncomparedtostandardofcarearandomizedcontrolledcrossovertrial
AT brutschemh telehealthmitigatescopddiseaseprogressioncomparedtostandardofcarearandomizedcontrolledcrossovertrial